Rare diseases
Investigational molecules
Locations
Chariteplatz 1, Mitte, 10117 Berlin, Germany
Charite Research Organisation GmbH in Berlin, Germany specialises in clinical trials of conditions such as Malignant melanoma, Colitis ulcerative, Dermatitis atopic, Hidradenitis, and other specialisations. This site conducts important research.
Charité Research Organisation advances cancer care by testing innovative therapies for a wide range of solid tumors and hematologic malignancies.
The trials aim to evaluate efficacy and safety of targeted agents and immunotherapies, helping to improve treatment outcomes for patients across Berlin and beyond.
Research at Charité focuses on immune‑mediated diseases, exploring new biologics that modulate the immune response.
These studies assess whether novel agents can reduce disease activity and improve quality of life for individuals living with chronic inflammation.
The site conducts trials targeting metabolic health, including obesity and diabetes management.
Objectives include testing agents that promote weight loss, improve glycemic control, and address associated cardiovascular risk factors.
Charité’s program evaluates therapies for cardiopulmonary conditions, aiming to alleviate symptoms and slow disease progression.
The research measures functional improvement, reduction in exacerbations, and overall patient well‑being.
Studies at Charité address serious bacterial infections and sepsis, testing new antimicrobial strategies.
Trials focus on safety and efficacy of novel antibiotics or adjunctive therapies to improve survival and recovery rates.
Clinical trials currently enrolling participants at this site.
Study on the Effectiveness and Safety of Deucravacitinib for Adults with Active Sjogren's Syndrome
GermanyEvaluation of zongertinib, fulvestrant and goserelin acetate in patients with HR‑positive HER2‑negative advanced breast cancer
GermanySafety and Efficacy of BMS-986528 with Tocilizumab in Patients with Refractory Rheumatoid Arthritis: A Phase 1/2a Open‑Label Study
GermanyEfficacy and safety of votoplam in adults with Huntington’s disease: a randomized, double‑blind, placebo‑controlled Phase 3 trial
GermanyStudy of Enfortumab Vedotin and Pembrolizumab for Bladder Preservation in Patients with Muscle‑Invasive Bladder Cancer
GermanyA study of LY4268989 and mirikizumab in adults with moderately to severely active ulcerative colitis
GermanyA Study of Felzartamab for Kidney Transplant Patients with Late Isolated Microvascular Inflammation
GermanyVusolimogene Oderparepvec with Nivolumab for Advanced Melanoma Patients Whose Cancer Progressed After Previous Immunotherapy Treatments
GermanyStudy on the Effects of Mexiletine for Treating Myotonic Dystrophy Types 1 and 2 in Patients
GermanyStudy on the Effectiveness and Safety of Myrrh, Coffee Charcoal, and Chamomile Extract for Patients with Diarrhea-Dominant or Mixed-Type Irritable Bowel Syndrome
GermanyLong-Term Safety and Efficacy Study of Mexiletine Hydrochloride for Patients with Myotonic Dystrophy Type 1 and Type 2
GermanyStudy on the Safety of VO659 for Patients with Spinocerebellar Ataxia Types 1, 3, and Huntington's Disease
GermanyMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
